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Macrophages have long been known for their phagocytic capabilities and immune defence; however,
their role in healing is being increasingly recognized in recent years due to their ability to polarize into
pro-inflammatory and anti-inflammatory phenotypes. Historically, biomaterials were designed to be
inert to minimize the host response. More recently, the emergence of tissue engineering and regenerative
medicine has led to the design of biomaterials that interact with the host through tailored mechanical,
chemical and temporal characteristics. Due to such advances in biomaterial functionality and an
improved understanding of macrophage responses to implanted materials, it is now possible to identify
biomaterial design characteristics that dictate the host response and contribute to successful tissue
integration. Herein, we begin by briefly reviewing macrophage cell origin and the key cytokine/
chemokine markers of macrophage polarization and then describe which responses are favorable for
both replacement and regenerative biomaterials. The body of the review focuses on macrophage
polarization in response to inherent cues directly provided by biomaterials and the consequent cues that
result from events related to biomaterial implantation. To conclude, a section on potential design
principles for both replacement and regenerative biomaterials is presented. An in depth understanding
of biomaterial cues to selectively polarize macrophages may prove beneficial in the design of a new
generation of ‘immuno-informed’ biomaterials that can positively interact with the immune system to
dictate a favorable macrophage response following implantation.
Introduction
Traditionally, macrophages (Greek: Macro – ‘Large’; Phage – ‘to
eat’) are thought of as providing the first line of defense to
infectious microorganisms through their phagocytic activities;
however, over the past two decades, their role in homeostasis,
tissue repair and remodeling has become increasingly evident [1].
Together with dendritic cells, mast cells, granulocytes (neutro-
phils, basophils and easinophils) and natural killer cells, macro-
phages constitute the innate immune system and are responsible
for recruiting other immune cells to the site of infection, removing
foreign pathogens by phagocytosis and activating both the com-
plement and adaptive immune systems [2]. While multiple cell
types are involved in tissue healing after injury, macrophages
play a pivotal role in mediating tissue remodeling by secreting
chemokines and cytokines that directly impact tissue repair [3].
Therefore, understanding the exact role of macrophages in tissue
healing processes, especially in events that follow biomaterial
implantation, will aid in the design of ‘immuno-informed’ materials
that elicit a favorable immune response upon implantation.
‘A biomaterial is a substance that has been engineered to take a
form which, alone or as part of a complex system, is used to direct,
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by control of interactions with components of living systems, the
course of any therapeutic or diagnostic procedure, in human or
veterinary medicine’ [4]. Biomaterials can be used to restore or
augment the physiological function of diseased or damaged tissues
via tissue replacement (e.g., permanent hip replacements) or
regeneration (e.g., degradable tissue engineering constructs). Cells
of the innate immune system are the first to respond to the
implantation of a biomaterial in vascularized tissue. Following
blood biomaterial contact, a layer of protein immediately adsorbs
onto the biomaterial surface, resulting in the formation of a blood
clot (provisional matrix) that is rich in growth factors, cytokines
and chemoattractants capable of recruiting cells of the innate
immune system to the injury site [5]. Subsequent to cell recruit-
ment, the severity of the ensuing acute and chronic inflammation
is dependent on the type of biomaterial implanted, the extent of
provisional matrix formation and the time taken to resolve the
inflammatory response. Without the provision of cues to direct
otherwise (i.e., in cases involving biologically inert biomaterials),
these events result in the formation of granuloma tissue, which
gives way to fibrous tissue formation and wound healing. These
sequential steps represent the full extent of a foreign body re-
sponse/reaction (FBR) following implantation of a biomaterial [6]
(Fig. 1); however, as this review highlights, there are a multitude
of ways in which these events can be altered to improve levels
of tissue remodeling and reduce or eliminate fibrous tissue
formation.
It is well established that microenvironmental cues presented by
biomaterials play a crucial role in modulating the response of cells
[7]. Physical properties such as substrate stiffness, topography,
pore size and size of wear debris; chemical properties such as
surface chemistry, ligand presentation and release of growth fac-
tors; and temporal properties, such as degradation rates, all influ-
ence the behavior of cells [8,9]. While much progress has been
made in understanding these effects on both somatic cells [10] and
stem cells [10,11], the effect of such biophysical and biochemical
cues on immune cells, specifically macrophages, is less well known.
This deficit in understanding macrophage responses is com-
pounded by the complex interplay between inherent biomaterial
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FIGURE 1
Natural innate immune response following biologically inert biomaterial implantation. Following the implantation procedure, a layer of proteins
from the surrounding vasculature adsorbs onto the biomaterial surface. This leads to infiltration and adherence of cells such as platelets, monocytes and
macrophages. These cells in turn release cytokines and chemokines that recruit tissue repair cells (e.g.: fibroblasts, Mesenchymal Stem Cells (MSC)) to the
inflammation site. These cells deposit collagen matrix and encapsulate the biomaterial in a fibrous tissue layer.
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properties and those that result from interactions with the local
environment as a consequence of biomaterial interaction.
To fulfill their plethora of functions, macrophages exhibit a
spectrum of transient polarization states that are influenced by
varying microenvironmental cues, some of which may be bioma-
terial-based. In this review, we begin by briefly describing the
origin of macrophages and their different polarization states.
The main body of the review will focus on the response of
macrophages to microenvironmental cues, primarily those inher-
ently presented by biomaterials but also consequent cues that
occur due to biomaterial implantation. To conclude, we will
describe how these concepts can be integrated into biomaterial
design to aid in the creation of immuno-informed biomaterials, a
new generation of immunomodulatory biomaterials that incorpo-
rate specific design principles to actively modulate the immune
response to implanted biomaterials.
Origin of macrophages
Macrophages can either reside in tissues or circulate in peripheral
blood; accordingly, they originate from two distinct sources. Until
recently, it was believed that macrophages were solely derived
from circulating monocytes, which arise from precursors in the
bone marrow as primary subsets of the mononuclear phagocyte
system; however, recent evidence suggests that some tissue resi-
dent macrophages (e.g., brain, liver, heart) may be generated in
utero during embryological development [12] (Fig. 2). These tissue
resident macrophages sustain their local populations by rapid
proliferation during injury events (Fig. 2b) [13]. In contrast, circu-
lating monocytes circulate in peripheral blood for a few days after
leaving the bone marrow environment, and differentiate into
macrophages (monocyte derived macrophages (MDM)) by extrav-
asation through the endothelium for steady state turnover (i.e.,
tissue homeostasis) or for mediating inflammatory events in
response to chemoattractants (Fig. 2a). While different subsets
of monocytes have been described, it is generally accepted that
the CD14++CD16 subpopulation represents a significant propor-
tion of circulating monocytes in humans [12].
Macrophage polarization and plasticity
Macrophages become activated following migration into inflamed
tissue, where they exhibit a spectrum of polarization states
related to their functional diversity. At one end of the spectrum
there is the pro-inflammatory M1 and at the other end the anti-
inflammatory M2 state (Table 1 for details and also the following
excellent reviews [9,14–16]).
The ‘classically activated’ or M1 phenotype emerges as a result
of macrophage interaction with pro-inflammatory signals such as
Interferon-g (IFN-g) and microbial products such as lipopolysac-
charide (LPS) [17]. M1 macrophages are capable of high antigen
presentation, as well as promoting Th1 differentiation of lympho-
cytes that produce pro-inflammatory cytokines (such as IFN-g and
IL-2) in response to intracellular pathogens. These cells display a
high level of iron retention and low iron export to restrict the
availability of microenvironmental iron capable of aiding bacterial
expansion, thereby preventing the growth of infections [18].
However, they also harm neighboring cells in the microenviron-
ment by producing toxic reactive oxygen intermediates and by
escalating the pro-inflammatory response [14]. In the context of
biomaterial implantation, while the initial presence of M1 macro-
phages promotes a necessary inflammatory response, a prolonged
M1 presence leads to a severe FBR, granuloma and fibrous encap-
sulation resulting in chronic inflammatory events and failure of
biomaterial integration. This is especially detrimental for regener-
ative biomaterials where the goal is to replace lost tissue and avoid
scar tissue formation [8].
The M2 phenotype of macrophages, which is referred to
as ‘alternatively activated’, is the result of activation by signals
(e.g., IL-4, IL-13) from basophils, mast cells and other granulocytes
Materials Today  Volume 00, Number 00  January 2015 RESEARCH
MATTOD-481; No of Pages 13
Please cite this article in press as: R. Sridharan, et al., Mater. Today (2015), http://dx.doi.org/10.1016/j.mattod.2015.01.019
FIGURE 2
Origin of macrophages. (a) Circulating monocytes are primarily derived from committed progenitor cells in the bone marrow (derived from HSC), which
migrate to peripheral blood. Monocytes extravasate through blood vessels when recruited as part of tissue homeostasis or injury events, where they
subsequently differentiate into monocyte derived macrophages. (b) In contrast, tissue resident macrophages are derived in utero in the yolk sac and
populate tissues such as the brain (microglia), liver (kuppfer cells) and the heart.
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[2]. M2 macrophages consistently express scavenger and mannose
receptors (CD206), release anti-inflammatory cytokines such as IL-
10 [19], display a high level of iron export aiding in tissue remo-
deling [18] and encompass a range of different subsets (i.e., M2a,
M2b, M2c) including ‘wound healing’ and ‘regulatory macro-
phages’ [20]. Within the M2 subsets, the M2a (induced by IL-4
and IL-13) and M2b (induced by immune complexes and toll like
receptor (TLR) agonists) subsets perform immune regulatory func-
tions by initiating Th2 lymphocyte anti-inflammatory responses
(through the secretion of IL-10, IL-1ra and IL-6) [21,22]. Alterna-
tively, the M2c subset is induced by IL-10 and plays a major role in
tissue remodeling and suppression of inflammatory immune reac-
tions by secreting transforming growth factor-b (TGF-b) and IL-10
[1,23]. The presence of such anti-inflammatory cytokines and the
tissue remodeling response can aid in the vascularization of re-
generative biomaterials by inhibiting fibrous tissue formation,
which greatly improves the integration of the biomaterial and
enables it to fulfill its intended function.
Unlike terminally differentiated cells, macrophages switch po-
larization states in response to their microenvironment. This is
emphasized by the contrasting gene expression during early and
late stages of the FBR [24], as well as their ability to adapt func-
tionality in response to the temporal presentation of stimuli [25].
The transitory nature of macrophages is also related to their para-
crine signaling mechanisms; for example, the induction of TNF-a
and IL-12 production by the pro-inflammatory (M1 polarizing)
cytokine, LPS, can be significantly dampened in the presence of
IL-4; a M2 polarizing cytokine produced by nearby M2 macro-
phages, basophils and mast cells [26]. This suggests that the
presence of macrophages in different states of polarization in the
same microenvironment can be harnessed to induce constructive
remodeling mechanisms that minimize the inflammatory reaction.
Harnessing microenvironmental cues to polarize
macrophages
Cells receive a diverse range of signals from their surrounding
environment through biochemical cues such as interactions with
other cells [27] and interactions with extracellular matrix compo-
nents [28], as well as biophysical cues such as externally applied
forces [29] and inherent material properties [11,30,31] (Fig. 3). The
integral effect of these cues on the cell’s current state directs its
future behavior. Although it has been suggested that a high M2:M1
ratio in the vicinity of implanted biomaterials leads to better
remodeling outcomes [32], prolonged presence of M2 macro-
phages can lead to the formation of detrimental foreign body
giant cells (FBGCs) [5]. Understanding the control of this
M2:M1 ratio through the modulation of biomaterial microenvi-
ronmental cues will therefore be a key step in the design of next
generation immuno-informed biomaterials to enhance positive
tissue remodeling, integration and regeneration. This section will
first review a range of inherent cues presented by a biomaterial,
followed by a section on consequent cues that are induced in the
microenvironment as a consequence of biomaterial implantation.
Inherent cues
Biophysical cues
Cells use integrin–ligand interactions to probe, attach and respond
to the properties of the underlying substrate, actively remodeling
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TABLE 1
Inducers and indicators of macrophage polarization.
Induced by Secretions (cytokines and chemokines) Expressed markers Functions Refs.
M1 IFN-g,
LPS
IL - 1b, 6, 12, 15, 18, 23;
TNF-a; CCL - 15, 20;
CXCL - 9, 10, 11, 13
h CD - 80, 86;
h MHC II;
i MRC1
Pro-inflammatory, killing of intracellular
pathogens by iron restriction, phagocytosis
[14,16,18]
M2a IL-4,
IL-13
IL - 10, 1ra;
CCL - 13, 14, 17, 18, 22, 23, 24, 26;
IGF-1; PDGF; TGF-b
CD - 163, 204, 206, 209;
YM1, Fizz1;
COX2, CLEC4A
Anti-inflammatory, parasitic immunity,
allergic responses
[1,21,22]
M2b LPS, ICs,
IL-1b
IL - 10, 1b, 6; TNF-a;
CCL - 1, 20;
CXCL - 1, 2, 3
h IL-10,
i IL-12;
MHC II; CD - 86, 163
Immuno-regulation, interaction with B cells,
both pro-inflammatory and anti-inflammatory
function
[1]
M2c IL-10,
TGF-b,
GCs
CCL - 16, 18; CXCL13;
TGF-b; matrix (versican, PTX3, a anti-trypsin)
h CD - 163, 204, 206;
i IL-6, TNF-a;
TLR - 1, 8
Matrix deposition, tissue remodeling and
pro-healing
[19,22,23]
IFN-g – interferon-gamma; LPS – lipopolysaccharide; IL – interleukin; TGF-b – transforming growth factor-beta; IC – immune complexes; GC – gluco-corticoids; TNF-a – tumor necrosis
factor-alpha; CCL – chemokine ligand; CXCL – a-chemokine ligands; IGF – insulin-like growth factor; PDGF – platelet derived growth factor; PTX3 – pentraxin 3; CD – cluster of
Differentiation; MHC – major histocompatibility complex; MRC1 – mannose receptor, C type 1; COX2 – cyclooxygenase 2, CLEC4A – C type lectin domain family 4 member A; TLR – toll like
receptor, SLAM – signaling lymphocyte activation molecule.
FIGURE 3
Inherent biomaterial cues (blue) and consequent cues (red) that affect
macrophage polarization.
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their cytoskeletal network and forming focal adhesions to affect
cell shape, motility and function [33]. While anchorage depen-
dent, low motile tissue cells rely heavily on stress fibers and
reorganized F-actin structures to attach to substrates, highly
motile cells derived from the myeloid lineage such as macrophages
and neutrophils have been shown to not possess stress fibers,
partly due to the fact that interactions with extracellular matrix
components do not form part of their innate function [34].
Instead, macrophages rely on short lived focal complexes, point
contacts and podosomes for migratory, phagocytic and mechan-
osensing roles [35]. Therefore, as detailed in the following
sections, cytoskeletal mediated mechanisms form an integral part
of macrophage response to biophysical cues.
Mechanical properties
One of the first studies exploring the effects of substrate stiffness
on macrophage function used mouse bone marrow derived
macrophages to show that stiff polyacrylamide particles were
phagocytized preferentially over soft particles of identical chem-
istry through a Rac-1 mediated mechanosensory pathway [36].
This role of mechanosensitivity in macrophage function was
further explored by Patel et al. [37], who reported that macrophage
elasticity (elastic modulus), which is mediated by substrate stiff-
ness, is actively dependent on actin polymerization and Rho-
GTPase activity. RAW 264.7 cells (a macrophage-like, Abelson
leukemia virus transformed cell line derived from BALB/c mice)
consistently exhibited organized actin filaments and filopodial
projections on stiff (150 kPa) polyacrylamide substrates; however,
upon treatment with a Rho-GTPase inhibitor (C. Difficile toxin),
cells appeared similar to those on softer (1.2 kPa) substrates, with
an absence of organized actin fibers in projections [37] (Fig. 4h,i).
Cell elasticity and phagocytic ability was also markedly higher for
cells cultured on stiff substrates, suggesting that substrate elasticity
modulates macrophage elasticity and phagocytosis through actin
polymerization [37]. The authors also showed that addition of LPS/
IFN-g to cells cultured on soft substrates increased cell spread area
(Fig. 4j), suggesting that polarization signals impact cell shape,
which has also been reported by several other groups [38,39].
Blakney et al. [40] showed that increasing the stiffness of 3D
polyethylene glycol–RGD (PEG–RGD) hydrogels (130, 240 and
840 kPa) increased the FBR and the thickness of the fibrous capsule
formed (30 mm for 130 kPa and 208 mm for 840 kPa). In vitro
studies with the same gels revealed an increase in production of
both pro-inflammatory (IL-1b, IL-6, TNF-a) and anti-inflammato-
ry (IL-10) cytokines with increasing stiffness of gels [40]. Based on
these results, the authors concluded that softer gels are capable of a
reduced inflammatory response; however, comprehensive quanti-
tative studies on the in vivo host response would be more indicative
of the mechanisms of hydrogel stiffness sensing by macrophages.
Micro and nano topography
From a biomaterial design perspective, modulating the surface
topography is a simple method to modulate cellular response
through control of cell shape and elasticity [41]. The modulation
of macrophage function, phenotype and polarization to varying
topography has been a subject of intense research for several
decades [31,42–47]. It was recently found that topographical cues
could override the effects of surface chemistry in certain materials,
especially in the first 6–48 hours after initial contact. RAW 264.7
cells seeded on substrates with three distinctive surface chemistries
((Poly (s-caprolactone) (PCL)), (Poly (Lactic acid)(PLA)), (Poly
(Dimethyl Siloxane) (PDMS))) but different width parallel gratings
(Fig. 4f,g) (with a range of 250 nm to 2 mm) showed increased
elongation with decreasing topography irrespective of the under-
lying surface chemistry; however, cells were largely insensitive to
topography changes smaller than 500 nm [46]. This study by Chen
et al. [46] also showed that gratings that were 1 mm wide elicited
the lowest inflammatory response in vitro (reduced levels of TNF-a
and VEGF secretion) compared to nano gratings and planar con-
trols. Interestingly, upon in vivo implantation, materials with 2 mm
gratings exhibited the least number of FBGC (1 mm grating mate-
rials were not analyzed). This trend has been confirmed by Sanders
et al. [48] who employed electrospun microfibers of different
thickness and compositions; 1–5 mm diameter fibers exhibited
the thinnest fibrous capsule formation compared to 6–10 mm
and 11–15 mm for all surfaces tested. The above results suggest
that topographical features in the size range 1–5 mm are well
tolerated upon implantation and exhibit a minimal host response.
Recently, a study by McWhorter et al. [39] reaffirmed the influ-
ence of topography on macrophage polarization and identified a
cell shape-mediated mechanism for this influence. Upon identify-
ing that M1 polarized cells assume a rounded shape and M2
polarized cells assume an elongated shape, the authors used engi-
neered cell culture substrates with 20 and 50 mm grooves to
control cell shape and consequentially direct polarization
(Fig. 4a–d). Moreover, the authors also reported that elongation
of cells synergized with M2 inducing cytokines (IL-4, IL-13) to
increase M2 polarization [39], suggesting that in addition to
directing polarization, biophysical cues directly presented by bio-
materials may be used to compliment the effects of factors already
present in the native environment. Interestingly, while cytoskel-
etal inhibitors abrogated shape-induced polarization, their pres-
ence did not affect the cells’ ability to respond to cytokine
stimulation, suggesting that shape-induced and cytokine-induced
polarization occur through distinct pathways [39].
3D geometric cues
While 2D substrates can be used as a means of easily answering
important fundamental questions about the behavior of macro-
phages in response to individual stimuli, 3D models better repre-
sent the complex in vivo microenvironment. Indeed, pore size of
3D scaffolds has been implicated in modulating the macrophage
phenotype. Sussman et al. [49] used Poly-hydroxy-ethyl-methac-
rylate (p-HEMA) scaffolds of small (34 mm) and large (160 mm) size
pores to study the macrophage response in a subcutaneous mouse
model three weeks after implantation. Interestingly, they observed
increased vascular density, an increased presence of M1 phenotype
and greater remodeling in the small pore size scaffold, suggesting
that M1 cells are not always detrimental to the tissue remodeling
process [49]. The authors were also the first to report specific
locations of polarized cells; as the number of M1+ cells increased
proximally to the implant while a smaller proportion of M2+ cells
were found adherent on the implant. This study also indicated
that rather than a fully polarized M1 or M2 phenotype, macro-
phages tend to assume a ‘functionally active’ phenotype, with up-
regulation of both M1 and M2 markers simultaneously [49]. The
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FIGURE 4
Morphological appearance of macrophages following cytokine stimulation and the effects of topography and stiffness on their polarization.
(a–c) Macrophage polarization using cytokines results in an alteration in cell shape. Mouse bone marrow derived macrophages (a) assume a pancake shape
when polarized with M1 cytokines (b) and an elongated phenotype with M2 cytokines (c) [adapted from [39]]; scale bar = 50 mm]. (d) By forcing these
shape changes upon the cells by topological constraints (surface patterning; scale bar = 50 mm), the elongated cells take on a more M2 like phenotoype in
the absence of cytokines (decreased iNOS expression and increased arginase expression) (e) [adapted from [39]]. RAW 264.7 macrophages assume an
elongated shape on PDMS substrates with 2 mm gratings compared to planar controls (f, g) [adapted from [46]]. When cultured on (h) soft (1.2 kPa) and (i)
stiff (150 kPa) polyacrylamide gels, RAW 264.7 macrophages assumed pancake and elongated shapes respectively and more M2 like characteristics with
increasing stiffness. Furthermore, cells on soft gels exhibited increased actin staining and cell spreading upon stimulation with LPS (j); cells were less
responsive to LPS stimulation at higher stiffnesses [adapted from [37]].
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influence of pore size on macrophage behavior was also observed
by Almeida et al., who 3D printed chitosan and PLLA scaffolds of
varying scaffold geometry and pore structure (orthogonal vs.
diagonal pores). They determined that scaffolds with diagonal
geometry had fewer FBGC and more elongated cells. This corre-
lates well with the McWhorter study [39] that implicates an
elongated cell shape in M2 responses. Interestingly, Almeida
et al. [43] also observed that cells that had increased metabolic
activity showed an increased inflammatory response. While this
was an in vitro study carried out with MDMs, the results again
suggest a ‘functionally active’ phenotype of macrophages, similar
to that observed by Sussman et al.
Biochemical cues
Surface chemistry
In a previous study by Brodbeck et al. [50], it was reported that
hydrophilic, anionic surfaces promoted the highest levels of
apoptosis of biomaterial adherent FBGC. Since FBGC are detri-
mental to the biomaterial due to their ability to increase oxidative
damage and recruit other inflammatory cells, the authors pro-
posed that inducing apoptosis in the adhered FBGC would
reduce the negative effects of adhered cells and improve tissue
remodeling [50,51]. While the studies by Brodbeck et al. and others
[52] suggest a dependence of the FBR on biomaterial surface
chemistry, there is conflicting evidence in the literature regarding
the extent of this dependence. For example, Schutte et al. and
Castner et al. argued that there are no differences between inert,
nondegradable materials with different surface chemistries one
month post-implantation and hence any short-term effect
observed is inconsequential [53,54]. This was also highlighted
by Chen et al. [46] (see section ‘Micro and nano topography’)
who demonstrated that subtle changes in topography override
the effects of surface chemistry. Recent studies have progressed
toward a possible explanation for the conflicting reports on the
surface chemistry dependence of the FBR. McBane et al. [55]
initially showed that a degradable hydrophobic, ionic polyure-
thane scaffold (D-PHI) was more successful than a tissue culture
plastic surface (TCPS) in eliciting an anti-inflammatory phenotype
from MDMs. This was characterized by significantly reduced levels
of TNF-a in the D-PHI group after 24 hours and significantly
increased levels of IL-10 at 72 hours when compared to the TCPS
group. To understand a potential mechanism for this surface
chemistry dependent immune response, a follow-up study by
the same group demonstrated that the variation in protein
adsorption, which was a function of surface chemistry, led to
the varied cytokine release profile of adhered MDM on different
surfaces [56]. This will be further discussed in the section ‘Protein
adsorption and ligand presentation’.
Consequent cues
As a consequence of biomaterial implantation, the local environ-
ment can be altered and subsequently affect macrophage
behavior. These consequential cues include biophysical cues, such
as dynamic loading; as well as biochemical factors, such as protein
adsorption on biomaterial surfaces and local hypoxia resulting
from the implantation procedure. Moreover, several tissue repair
cells such as mesenchymal stem cells (MSC) selectively home to
implant sites through paracrine signaling mechanisms [57]. The
cytokines, chemokines and growth factors released by these infil-
trating cells and cells already present in the microenvironment
of the implant play a major role in determining the response of
the local macrophage population to injury.
Dynamic loading
Upon implantation, a scaffold can undergo dynamic loading due
to pulsing vessels, active joint loading, or proximity to contracting
muscles resulting in dynamic or cyclical strain on cells. Indeed, an
up-regulation of both M1 and M2 cytokine release was observed on
applying a 7% cyclical load to PCL bisurea strips seeded with
monocyte derived macrophages, with cells progressively polariz-
ing toward an M2 phenotype with increasing time [58]. Another
study quantified the effect of cyclical pressure on cytokine/
chemokine production in cultured human macrophages, with
an increase in pro-inflammatory cytokines (TNF-a, IL-6, IL-1b)
compared to controls for all levels of cyclical pressures tested
(17–138 kPa) [59]. Moreover, this effect was further elevated with
the presence of polyethylene particles (representing wear debris
from implants). The authors proposed that this increase in release
of pro-inflammatory cytokines in response to cyclical pressure and
presence of wear debris contributes toward aseptic loosening of
implants [59]. Hence, better implant design and fixation methods
to modulate local levels of dynamic loading and minimizing
wear debris are potential avenues for improving long term survival
of implanted materials.
Protein adsorption and ligand presentation
Protein adsorption on the surface of biomaterials occurs post
implantation and control over it is not inherently designed into
the biomaterial, making it a consequent cue. Protein adsorption,
through the subsequent presentation of ligands that differentially
bind and activate integrins, can trigger the production of a wide
range of inflammatory cytokines and chemokines through integ-
rin–ligand interactions. The study by McBane et al. described in
section ‘Biochemical cues’ observed that while surface chemistry
per se may not modulate the FBR, the selective adsorption of
proteins by different surfaces could account for observed differ-
ences in FBR. Moreover, earlier studies have indicated differences
in cellular behavior on substrates with different ligand confirma-
tions [60], suggesting that not only the type of protein adsorption,
but also the orientation of ligands presented could affect the
macrophage response.
Zaveri et al. demonstrated the effects of varying integrin binding
on macrophage responses by subcutaneously implanting polyeth-
ylene terephthalate (PET) biomaterials and disrupting the function
of integrin Mac1 (leukocyte integrin that binds to fibrinogen) and
RGD (ligand present in fibronectin, fibrinogen, vitronectin and
laminin [61]) binding integrins via a mouse knock out model
and integrin blocking respectively [28]. Mac1 knockout mice
displayed reduced cytokine secretion compared to the wild type
controls and had reduced fibrous capsule thickness by 27%.
Similarly, blocking RGD ligands by releasing a high affinity
RGD peptide decreased the fibrous capsule thickness by 45%
[28]. The authors conclude that this pronounced effect is likely
due to a more widespread effect of RGD – which can bind to a
large selection of integrins. This study demonstrates the potential
for modulating macrophage behavior via inhibition of integrin
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interactions common to all cells (e.g., RGD). However, this could
have detrimental effects on achieving sufficient biomaterial inte-
gration; hence, blocking targeted integrins may represent a pre-
ferred option for minimizing host response by minimizing
integrin–ligand binding. From this section, it is clear that while
protein adsorption (and ligand presentation resulting from pro-
tein adsorption) can considerably moderate the inflammatory
response, protein adsorption itself can be modulated by changing
inherent material properties such as surface chemistry. Moreover,
emerging approaches such as direct ligand patterning on bioma-
terial surfaces to promote preferential protein attachment repre-
sent modifications to inherent cues presented by biomaterials to
further affect consequent cues.
Hypoxia
Apart from changes in the surrounding biophysical and biochem-
ical cues, implantation of a biomaterial can provide consequent
cues via alterations to the local hypoxic environment caused by
the destruction of blood vessels supplying the injured tissue [62].
Macrophages accumulate in hypoxic environments to release pro-
healing and pro-angiogenic factors such as vascular endothelial
growth factor (VEGF), platelet derived growth factor (PDGF) [63]
and enzymes such as Cyclooxygenase 2 (COX2) [64]. The response
of macrophages to hypoxic environments is thought to be medi-
ated by transcriptional factors hypoxia inducible factor (HIFs) 1
and 2 [65]. While the role of macrophages in a hypoxic wound
environment is beneficial to promote vascularization of implanted
scaffolds, it is noted that the hypoxic environment present in
cancerous tissue actively recruits tumor associated macrophages
(TAMs), which closely resemble the M2 phenotype. This has led to
an intense research focus on TAM targeted therapies within the
cancer field [66,67]. Undoubtedly, further research on hypoxia in
the implant environment and its effect on macrophages will
provide opportunities to take advantage of hypoxic conditions
to aid in wound healing mechanisms.
Interaction with other cells in microenvironment
The capacity of biomaterials to act as a cell carrier and their impact
upon host cells in situ can also provide a number of consequent
cues to affect macrophage behavior and modulate the inflamma-
tory response. In this section, we will review two main cell types
known to play a major role in mediating macrophage response
to biomaterials; lymphocytes and mesenchymal stem cells.
Lymphocyte/macrophage interactions
In addition to the well-established role of macrophages in response
to implanted biomaterials, emerging research suggests that lym-
phocytes are key cellular determinants of biomaterial outcomes
[68]. The bidirectional interaction between the two cell types is
well established; indeed, the polarization paradigm of macro-
phages is derived from their interaction with lymphocytes [14].
TH1 lymphocytes release IFN-g which polarizes cells toward an M1
phenotype, secreting several pro-inflammatory cytokines and che-
mokines, some of which (IL-12, CXCL-10) escalate the inflamma-
tory response by recruiting more Th1 lymphocytes [68,69].
Likewise, Th2 lymphocyte derived signals such as IL-4 and IL-13
direct M2 polarization of macrophages that in turn produce che-
mokines such as CCL17, CCL22 and CCL24, which enhance the
recruitment of Th2 lymphocytes [68]. Moreover, macrophages
and lymphocytes regulate each other through the production of
cytokines and chemokines through every step of the FBR; with
TH2 derived cytokines (IL-4, IL-13) driving the formation of FBGCs
[70]. Indeed, it has been shown in an in vitro lymphocyte/macro-
phage co-culture study that juxtacrine (cell-cell contact) and
paracrine (soluble factors) signaling play a crucial role in deter-
mining inflammatory response; and that this response can be
mediated by varying surface chemistry of materials [71]. This
tightly controlled regulation and complex bidirectional interac-
tion of macrophages is also observed with dendritic cells, neutro-
phils and other immune cells present in the environment (which
are comprehensively reviewed in a number of publications
[15,72,73]).
MSC/macrophage cross-talk
Mesenchymal stem cells or multipotent stromal cells (MSCs) are
adult stem cells that are found in tissues such as the bone marrow
and can differentiate toward a multitude of lineages that consti-
tute tissues including fat, bone, cartilage, muscle and skin, making
them popular in regenerative medicine strategies [74,75]. Due to
their ability to secrete anti-inflammatory cytokines such as IL-10
and vascular endothelial growth factor (VEGF), they are addition-
ally being explored for their immunomodulatory capabilities
[76,77]. Their use in clinical trials for treating immune diseases
such as graft versus host disease (GvHD) and Crohn’s disease is
ongoing [78]. Upon implantation of a biomaterial, there are two
distinct sources of MSCs that can interact with macrophages in the
implant environment: endogenously derived MSCs and those
administered as part of the implant/therapy. Chen et al. [27]
showed that factors secreted within bone marrow MSC (BM-
MSC) conditioned medium (cultured under hypoxic conditions)
actively recruit macrophages and endothelial cells to a wound
thereby enhancing wound healing and that MSC conditioned
medium increased in vitro migration of endothelial cells and
keratinocytes. BM-MSC were shown to release chemo-attractants
such as macrophage inflammatory protein (MIP) and monocyte
chemo-attractant protein (MCP), which recruit more monocytes/
macrophages. Additionally, BM-MSC release cytokines such as
VEGF, which promote vessel formation at site of implantation/
injury and allow for further recruitment of cells [27]. When
injected in vivo in a mouse model, MSC conditioned medium
led to greatest wound closure after 14 days compared to controls.
It has also been shown that macrophages mediate MSC viability
and proliferation in vitro [79], and that MSC are early regulators of
inflammation [80] (Fig. 5).
Interestingly, it was recently observed by Seebach et al. that
MSC-filled fibrin constructs promoted infiltration of M1 macro-
phages accompanied by early signs of vascularization, which was
absent in fibrin constructs without MSC (Fig. 6c,d,g,h). Gene
expression analysis at day 3 and 6 revealed no differences in
expression of TNF-a, IL-1b or IL-10 between cell-free and MSC
filled constructs [81]; however, later timepoints were not analyzed.
Research from our group suggests that marked differences in M1
and M2 presence is observed 4 and 8 weeks after implantation
of cell free and MSC filled porous collagen-based scaffolds
(Fig. 6a,b,e,f)[82], hence analyzing later timepoints in the fibrin-
MSC study might shed light on the beneficial effect of MSC in
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promoting tissue integration. Apart from the materials used and
the analysis time-points, one of the main differences between the
two studies was the 4 week in vitro culture of the collagen-MSC
scaffolds. Matrix deposition during this period of in vitro culture is
likely to have hindered penetration by immune cells after implan-
tation and may account for the limited tissue integration observed
in these collagen-MSC scaffolds. However, results from both stud-
ies agree with conclusions by Brown et al. [83], who demonstrated
that the presence of even an autologous cellular component
attracted M1 cells, which was not observed in cell free constructs.
This further suggests that the M1 response observed by Seebach
et al. and Lyons et al. is a direct effect of the presence of a cellular
component (and not necessarily due to the presence of MSC
specifically). Nevertheless, it is clear that additional research needs
to be undertaken with cell-free and MSC-seeded tissue engineering
constructs to understand the effect of MSC presence in such
scaffolds.
Peripheral blood monocytes co-cultured with MSC have been
defined under a new paradigm by Kim et al., and are referred to as
MSC educated macrophages (MSC-Mo) [84]. These cells have a
unique anti-inflammatory signature (IL-10 high, IL-12 low, IL-6
high, and TNF-a low) and are distinct from monocyte derived M2
macrophages, due to their increased production of IL-6 [85]. More
research is requisite for understanding the in vivo functionality of
this phenotype, and for shedding light on macrophage/MSC
interactions especially in the presence of diverse biophysical
and biochemical cues.
Designing immuno-informed biomaterials
With the many exciting advances in our understanding of macro-
phage-biomaterial biology, we can now begin to integrate this
information into design choices for novel immuno-informed
biomaterials. The design criteria of these biomaterials can be
specified by broadly dividing them into two categories: (1) replace-
ment biomaterials that integrate and remain permanently fixed
upon implantation, with minimal inflammation and fibrous tissue
formation; and (2) regenerative biomaterials that provide initial
support and stimulate tissue formation while degrading at a
controlled rate over time. Importantly, immuno-informed deci-
sions have to be integrated into, and traded off against the other
design goals of the device (such as tailored mechanical properties
for bone or cartilage regeneration); however, our emerging under-
standing suggests that macrophage polarization can be affected in
a plethora of ways, providing several potential avenues through
which immuno-informed biomaterials can be designed (Fig. 6).
Replacement biomaterials
Replacement biomaterials include long term (15–20 years; after
which even the best implants need replacement due to aseptic
loosening and stress shielding) implantable devices made of poly-
meric/metallic materials that are mechanically stable and aim to
exhibit minimal host response upon implantation [8]. Historical-
ly, such implants were preferred to be biologically inert, to mini-
mize interactions between the implant and cells in the
microenvironment [86]. This is achieved by careful selection of
material components that: allow for native protein adsorption on
the surface, which can contribute to provisional matrix formation
and act as a buffer between the biomaterial and the host; and/or
whose deterioration products (e.g., as a result of wear) are readily
excreted through the kidneys. Furthermore, ensuring that motion
between the implant and the host is minimized through appro-
priate surgical techniques will minimize scar tissue formation; this
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FIGURE 5
In vivo host response in bone defects to tissue engineered collagen based constructs (left) at 8 weeks and fibrin hydrogels (right) after 6
days. M1 macrophages were no longer present in the defect site after 8 weeks (cells were present at 4 weeks, data not shown) in cell free collagen-based
scaffolds (a) but were present at the periphery and within the scaffold with MSC (b). M2 macrophages were observed in the periphery and inside the
scaffold in cell free scaffolds (e) but only in the periphery in the scaffolds with MSC (f ). For fibrin hydrogels, both M1 and M2 positive cells were scarcely
present in the cell free constructs (c, g). In the MSC-filled fibrin hydrogel group, while M1 macrophages were found in cell dense areas (d), M2 macrophages
had accumulated throughout the scaffold, especially in the migration front (h). Scale bars – 100 mm. [a, b, e, f [adapted from [82]] [c, d, g and h adapted
from [81]].
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is essential in implants placed in bone, for example, but may be of
less importance for subcutaneous implants (e.g., implantable car-
dioverter defibrillator (ICD)) and irrelevant for implants in cavities
(e.g., intrauterine devices).
Despite the desire to minimize the interaction between implant
and host, recent evidence suggests that promoting specific inter-
actions between cells and the implant can boost immune accep-
tance and integration. For example, titanium implants used for
bone tissue replacement (e.g., hip/knee replacements, dental
implants) show higher osseointegration when the surface is modi-
fied to permit attachment and migration of bone forming cells
[87,88]. Such modifications to the biomaterial surface not only
promotes greater tissue remodeling, but also has the potential to
subsequently induce a pro-M2 response due to better tissue inte-
gration, thereby creating a favorable immune environment for
remodeling. Current research in this area focuses on varying
surface chemistries and roughness to modulate the macrophage
response toward an M2 phenotype, which will in turn secrete pro-
healing and anti-inflammatory factors to mitigate the formation
of fibrous tissue [5,87,89]. To promote successful integration of the
implant, the host tissue should ideally remodel and reform around
the implant to restrict further inflammatory reaction. Further-
more, the boundary between replacement medical devices and
regenerative medicine constructs is increasingly overlapping, as
many coating technologies on replacement devices are now func-
tionally similar to those used for regenerative medicine.
Regenerative biomaterials
The increasing exploration and use of regenerative biomaterials
is due to their ability to restore lost structural and functional
properties of injured and diseased tissue. Such constructs are
typically designed to be biodegradable over a period of several
days to months depending on the application, with regeneration
of host tissue being structurally supported and promoted by
matrices that eventuate in degradation products designed to be
absorbed or excreted by the body [5,90]. Upon surgical implanta-
tion, it has been shown that the initial M1 response is responsible
for recruiting inflammatory cells to the site of injury and for
instigating the ensuing foreign body response [5,86,91], which
are necessary events for wound healing. Following this initial
response; however, the prolonged presence of M1 cells leads to
the production of toxic reactive oxygen intermediates and results
in excessive oxidative damage of the biomaterial [14,15]. Further-
more, fibrous capsule formation as a result of extended inflamma-
tion could impair the capacity of regenerative biomaterials to
promote tissue formation or degrade in the intended manner.
Therefore, a subsequent transition to the M2 phenotype – which
promotes tissue remodeling and repair – is generally believed to
be a favorable adaptation [8].
In designing an immuno-informed regenerative biomaterial,
the most targeted method of controlling the immune response
would be to release factors (e.g., IL-4, IL-10, steroids) that over-
whelm native signaling and direct polarization [92,93]. This could
be done by incorporating growth factors, gene delivery vectors or
small molecule drugs (e.g., steroids) into controlled release systems
[94], either alone or as part of a system that is designed for multi-
factor release [93]. The advantages and effectiveness of this ap-
proach remains to be evaluated against the potential cost increase.
Beyond incorporation of stimulatory bioactive molecules,
several biophysical and biochemical properties can be exploited
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FIGURE 6
Current and evolving design principles for immuno-informed design of (a) replacement biomaterials and (b) regenerative biomaterials. The
pros and cons of these effects on the immune response should be evaluated against their effects on all cell types involved in the host response.
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to affect macrophage polarization. Although the exact depen-
dence of macrophage phenotype on stiffness is not fully conclu-
sive, future investigations will no doubt add to the growing body
of knowledge relating to the effect of biomaterial mechanical
properties on macrophage behavior [37,38]. Investigations into
the role of topography on polarization are strongly suggestive
of the advantages of stimulating macrophage elongation for pro-
moting M2 polarization [39]. This can be achieved by micro-
patterning the surface – studies suggest around 1 mm thick strips
or fibers are optimum [46] – to control attachment, or could be
achieved by patterning macrophage ligands on the surface to
promote elongation of cells. Pore size was also shown to affect
macrophage response–as the incorporation of scaffolds with a pore
size of 34 mm was shown to reduce fibrous encapsulation [49];
however, interestingly, more M1 cells were found on scaffolds
with this pore size when compared with those with a larger pore
size (160 mm), again suggestive of the necessity of the initial M1
response [49]. The consequential effects of adapting these bioma-
terial design considerations to directly modulate macrophage
behavior need to be done with consideration for the effects on
other cell types (e.g., the known dependence of MSC behavior on
scaffold stiffness [95]).
While it is generally accepted that there are positive healing
outcomes with the presence of M2 cells in the implant environ-
ment [8,96], it is still unclear whether positive healing outcomes
are predominantly governed by the influence of macrophages and
their orchestration of cellular events, or whether it is the overrid-
ing influence of other cells and microenvironmental cues, which
are then also responsible for directing macrophage behavior. There
is increasing evidence that MSCs stimulate polarization of macro-
phages towards the M2 state; whether this applies only to exoge-
nously administered MSC or also endogenously homed MSC
remains to be seen. Moreover, hypoxic effects and endogenous
MSC could already be present in the injured tissue that requires
biomaterial implantation; hence, efficient methods to harness
these already existing M2 polarizing cues could warrant further
investigation. Ultimately, it is evident that several routes exist for
polarizing macrophages to assume a favorable M2 phenotype;
however, a practical and efficient approach to the design of
immunomodulatory biomaterials still warrants further research.
Conclusions
The recent surge in our understanding of macrophage polarization
and its role in wound healing has seen an advance in knowledge
from utilizing growth factors alone to affect polarization to an
understanding of a diverse set of biophysical and biochemical cues
that affect polarization. Ongoing research is unveiling more details
of inherent biomaterial cues as well as consequent cues and their
role in polarizing macrophages and immuno-modulation. With
this in mind, current and future research should be aimed at
gaining an increased understanding of such biomaterial-based
factors involved in polarizing macrophages. This insight into
macrophage-biomaterial biology and an improved understanding
of other components of the immune system such as neutrophil
and dendritic cell modulation will ultimately lead to a definitive
set of design principles to aid in the design of a new generation of
immuno-informed biomaterials that can actively direct the innate
immune system.
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